EMA calls for transparency and collaboration to ensure high-quality observational research in the context of COVID-19
Editor’s highlights from the Journal of Comparative Effectiveness Research – May 2020
ISPOR 2020 – inside the second plenary: moving from population health to 'precision population health'
ISPOR 2020: do managed entry agreements for ATMPs exist in Germany? Curative and genetic therapies abstract highlights
ISPOR 2020 – inside the first plenary: both necessity and science give rise to invention
ISPOR 2020: how may we enable faster access to multi-indication orphan products? Rare disease and orphan drug abstract highlights
Events, ISPOR, Health technology assessment, Medical devices, pharmaceuticals and vaccines, Methodology, Real-world evidence, Stakeholder engagement
Peek behind the paper: is high-dose baclofen use associated with increased risk of encephalopathy in individuals with chronic kidney disease?
Editor’s highlights from the Journal of Comparative Effectiveness Research – April 2020
[ON DEMAND] Improving efficiency in health technology assessment with advanced software: a panel discussion